|
Nectar Lifesciences Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
257.90 Cr.
|
P/BV
|
0.45
|
Book Value (Rs.)
|
25.41
|
|
52 Week High/Low (Rs.)
|
22/9
|
FV/ML
|
1/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
21/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 |
| | | | |
| | | | |
| INCOME | | | |
| Revenue From Operations [Gross] | 0.00 | 1908.40 | 1925.83 |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 238.43 | 241.75 |
| Revenue From Operations [Net] | 0.00 | 1669.97 | 1684.09 |
| Total Operating Revenues | 0.00 | 1669.97 | 1684.09 |
| | | | |
| Other Income | 9.29 | 4.99 | 14.58 |
| Total Revenue | 9.29 | 1674.97 | 1698.66 |
| | | | |
| EXPENSES | | | |
| Cost Of Materials Consumed | 0.00 | 1250.72 | 1242.45 |
| Operating And Direct Expenses | 0.00 | 163.22 | 184.64 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 0.00 | 117.29 | -40.21 |
| Employee Benefit Expenses | 1.91 | 96.48 | 84.67 |
| Finance Costs | 36.13 | 74.58 | 87.14 |
| Depreciation And Amortisation Expenses | 0.34 | 62.39 | 60.72 |
| Other Expenses | 58.79 | 71.83 | 60.98 |
| Total Expenses | 97.17 | 1836.50 | 1680.39 |
| | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -87.88 | -161.53 | 18.27 |
| | | | |
| Profit/Loss Before Tax | -87.88 | -161.53 | 18.27 |
| | | | |
| Tax Expenses-Continued Operations | | | |
| Current Tax | -30.53 | -47.85 | 13.27 |
| Total Tax Expenses | -30.53 | -47.85 | 13.27 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -57.35 | -113.68 | 5.00 |
| | | | |
| Extraordinary Items | 163.37 | 0.00 | 0.00 |
| Profit/Loss From Continuing Operations | 106.03 | -113.68 | 5.00 |
| | | | |
| Profit/Loss From Discontinuing Operations | -537.66 | 0.00 | 0.00 |
| Total Tax Expenses Discontinuing Operations | -138.74 | 0.00 | 0.00 |
| Net Profit/Loss From Discontinuing Operations | -398.92 | 0.00 | 0.00 |
| Profit/Loss For The Period | -292.89 | -113.68 | 5.00 |
| Consolidated Profit/Loss After MI And Associates | -292.89 | -113.68 | 5.00 |
| | | | |
| OTHER INFORMATION | | | |
| | | | |
| EARNINGS PER SHARE | | | |
| Basic EPS (Rs.) | -13.40 | -5.07 | 0.22 |
| Diluted EPS (Rs.) | -13.40 | -5.07 | 0.22 |
